You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML newly diagnosed

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

Recruiting
  • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
  • Basic chemotherapy + UCB transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Oct 9, 2022

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in combination with azacitidine and CAG
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

    Recruiting
    • Newly Diagnosed Acute Myeloid Leukemia (AML)
    • SKLB1028 Dose Escalation
    • Chengdu, China
      West China Hospital of Sichuan University
    Jun 30, 2022

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

    Available
    • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
    • (no location specified)
    Oct 18, 2022

    Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

    Recruiting
    • Acute Myeloid Leukemia
    • Azacitidine Combined With Venetoclax and ATRA group
    • Suzhou, China
      the First Affiliated Hospital of Soochow University
    Dec 8, 2022

    AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

    Not yet recruiting
    • AML, Adult
    • Amersfoort, Netherlands
    • +17 more
    Aug 23, 2023

    Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Tagraxofusp (Cycles 1-2)
    • +2 more
    • (no location specified)
    Jun 28, 2022

    Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • AML Stage, Adult
    • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
    • Xiamen, Fujian, China
      Bing Xu
    Oct 29, 2022

    Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

    Withdrawn
    • Acute Myeloid Leukemia
    • (no location specified)
    May 18, 2022

    AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

    Recruiting
    • AML, Adult
    • Chicago, Illinois
    • +1 more
    Aug 17, 2022

    Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

    Completed
    • Acute Myeloid Leukemia (AML)
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Jul 27, 2022

    Acute Myeloid Leukemia Trial in Tampa (Vyxeos, Gemtuzumab Ozogamicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 23, 2022

    Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Suzhou, Jiangsu, China
      Qiu Huiying
    Mar 28, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Different induction chemotherapy regimens
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Sep 27, 2023

    Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Venetoclax plus Azacitidine
    • standard of care chemotherapy plus gemtuzumab ozogamicin
    • Essen, NRW, Germany
    • +17 more
    Jun 6, 2023

    Acute Myeloid Leukemia Trial in Baltimore, Chapel Hill, Charleston (pembrolizumab, Azacitadine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +2 more
    May 19, 2022

    AML Trial (APVO436)

    Withdrawn
    • AML
    • APVO436
    • (no location specified)
    Nov 29, 2021

    Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Jerusalem, Yerushalayim, Israel
      Shaare Zedek Medical Center
    Oct 25, 2022

    Acute Myeloid Leukemia Trial (Sulfasalazine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Oct 11, 2022

    Acute Myeloid Leukemia, Venetoclax Trial in Kunming (combination of venetoclax and HAA regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax
    • combination of venetoclax and HAA regimen
    • Kunming, Yunnan, China
      The Second Affiliated Hospital of Kunming Medical University.
    May 29, 2023

    Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +2 more
    Apr 4, 2022